

Fundamental dimension Equity attribute | HAINPeer $0.15▼-4.34% Cap $13.65MP/E -0.0x QuantScore27/100 | BRIDLeader $5.50▲+0.55% Cap $49.92MP/E -3.5x QuantScore44/100 | BRLSPeer $0.98▼-5.77% Cap $21.03MP/E -1.2x QuantScore21/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
23/100 |
48/100 |
28/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 67/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 10/100 | 56/100 | 23/100 |
Growth Revenue / earnings growth & margins | 18/100 | 5/100 | 33/100 |
Sentiment Analyst ratings, targets & revisions | 50/100 | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -3.5x | -1.2x |
Forward P/E (next FY) | 8.0x | — | — |
EV / EBITDA (TTM) | -2.9x | -4.5x | -4.5x |
Price / Sales | 0.0x | 0.2x | 0.6x |
Price / Free Cash Flow | 0.2x | -7.7x | -3.9x |
PEG ratio | -0.00 | 0.01 | -0.07 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 5 / 9 | 3 / 9 |
Altman Z-Score | -0.29 (Distress) | 3.33 (Safe) | -4.54 (Distress) |
Total debt / equity | 3.94 | 0.09 | -1.15 |
Quick ratio | 0.3x | 1.0x | 0.0x |
Interest coverage | -3.6x | -42.0x | -1.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -13.2% | +3.3% | -11.2% |
Net income growth YoY | +42.6% | -295.1% | +25.1% |
Gross margin (TTM) | 20.1% | 18.8% | 22.3% |
Operating margin (FY) | -15.0% | -8.2% | -24.7% |
FCF margin (FY) | 4.3% | -4.0% | -14.9% |
5. Trailing price performancePrice change over period |
1M return | -71.2% | -6.8% | -26.9% |
3M return | -71.7% | -14.5% | +4.8% |
6M return | -83.8% | -26.9% | +7.7% |
Year to date | -86.0% | -29.5% | -51.0% |
1Y return | -89.6% | -30.9% | -71.1% |
3Y return | -98.7% | -49.1% | -91.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-16.15 -10868.2% premium | $15.92 +189.5% upside | $-16.91 -1825.3% premium |
Wall Street consensus target | $1.00 +566.7% · range $1.00–$1.00 | — — | — — |
Consensus stance | 30% Buy64% Hold7% Sell | — | — |